Skip to main content

Table 6 Meta-analysis for the efficacy of colchicine on hospital discharge rate in patients with COVID-19

From: The role of colchicine in the management of COVID-19: a Meta-analysis

Study

Type of study

Relative Risk

95% CI

P-value

Recovery Collaborative Group 2021

RCT

0.98

0.94–1.03

0·44

Sandhu et al. 2020

NRCT

4.76

1.96–11.11

0.00032

Brunetti et al. 2020

Cohort

5.0

1.25–20.08

0.023

Fixed Effect Model

0.99

0.12–7.85

–

  1. 95% CI 95% confidence interval, RCT Randomized controlled trial, NRCT Nonrandomized controlled trial